Literature DB >> 11276010

Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours.

S Hirota1, T Nishida, K Isozaki, M Taniguchi, J Nakamura, T Okazaki, Y Kitamura.   

Abstract

Gastrointestinal stromal tumours (GISTs) are the most common mesenchymal tumours of the human gastrointestinal tract. Previous studies of GISTs found gain-of-function mutations of the c-kit gene, which encodes a receptor tyrosine kinase (KIT). All the mutations were confined to exon 11, which encodes the juxtamembrane domain. By further examination of the whole coding region of c-kit complementary DNA in 35 GISTs, two were found to show the identical mutation at exon 9, which encodes the extracellular domain. The aims of the present study were to examine the frequency of the extracellular domain mutation and to determine whether the mutation is a gain-of-function type or not. Genomic DNA was extracted from paraffin-embedded tissues of 133 GISTs and exon 9 of the c-kit gene was amplified by polymerase chain reaction. Screening of the mutation was carried out by single-strand conformation polymorphism analysis and direct sequencing was done. Mutant c-kit cDNA was transfected into 293T human embryonic kidney cells and the magnitude of autophosphorylation of the mutant KIT was examined with or without the ligand of KIT, stem cell factor (SCF). In total, seven GIST cases (approximately 5%) were found with the identical mutation at exon 9. The mutant KIT exhibited constitutive autophosphorylation without SCF stimulation. The prognosis of the patients with the extracellular domain mutation was comparable to that of the patients with the juxtamembrane domain mutation. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11276010     DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH818>3.0.CO;2-E

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  43 in total

1.  Gene expression studies on soft tissue tumors.

Authors:  Matt van de Rijn; Brian P Rubin
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

2.  KIT gene mutations in gastrointestinal stromal tumors: more complex than previously recognized?

Authors:  Jonathan A Fletcher; Christopher D M Fletcher; Brian P Rubin; Leonie K Ashman; Christopher L Corless; Michael C Heinrich
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

3.  A case of gastrointestinal stromal tumor with internal tandem duplication in the 3'-terminal of the KIT juxtamembrane domain.

Authors:  Hideaki Kato; Makoto Nakamura; Etsuro Orito; Ryuzo Ueda; Toyonori Tsuzuki; Masashi Mizokami
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

4.  A quality control program for mutation detection in KIT and PDGFRA in gastrointestinal stromal tumours.

Authors:  Isabelle Hostein; Maria Debiec-Rychter; Sylvianne Olschwang; Pierre-Paul Bringuier; Louisa Toffolati; David Gonzalez; Sébastien Forget; Fabienne Escande; Lucyna Morzuch; Elena Tamborini; Nicolas Faur; Silvana Pilotti; Paolo Dei Tos; Jean-François Emile; Jean-Michel Coindre
Journal:  J Gastroenterol       Date:  2011-02-01       Impact factor: 7.527

5.  Primary large gastrointestinal stromal tumor of the liver: report of a case.

Authors:  Toshiya Ochiai; Teruhisa Sonoyama; Shojiro Kikuchi; Hisashi Ikoma; Takeshi Kubota; Masayoshi Nakanishi; Daisuke Ichikawa; Shijiro Kikuchi; Hitoshi Fujiwara; Kazuma Okamoto; Chohei Sakakura; Yukihito Kokuba; Hiroki Taniguchi; Eigo Otsuji
Journal:  Surg Today       Date:  2009-06-28       Impact factor: 2.549

Review 6.  An update on molecular genetics of gastrointestinal stromal tumours.

Authors:  L Tornillo; L M Terracciano
Journal:  J Clin Pathol       Date:  2006-06       Impact factor: 3.411

7.  Prognostic value of KIT mutation in gastrointestinal stromal tumors.

Authors:  Xiao-Hong Liu; Chen-Guang Bai; Qiang Xie; Fei Feng; Zhi-Yun Xu; Da-Lie Ma
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

8.  Analysis of CD117-negative gastrointestinal stromal tumors.

Authors:  Chin-Yuan Tzen; Bey-Liing Mau
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

Review 9.  [Gastrointestinal stromal tumors. A morphologic and molecular genetic independent tumor entity with new therapeutic perspectives].

Authors:  G Mechtersheimer; T Lehnert; R Penzel; S Joos; G Egerer; H F Otto
Journal:  Pathologe       Date:  2003-03-21       Impact factor: 1.011

10.  Colorectal gastrointestinal stromal tumors: a brief review.

Authors:  Rishindra M Reddy; James W Fleshman
Journal:  Clin Colon Rectal Surg       Date:  2006-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.